Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Steven Gundry

Thoracic Surgery (Cardiothoracic Vascular Surgery) Palm Springs, CA Medical Doctor

NPI 1801889050 CMS profile 671028

555 E Tachevah Dr, 3W-103, Palm Springs, CA 92262

Open in the dashboard

General payments

$1,634,689

27 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Steven Gundry of Palm Springs, CA is reported in the CMS Open Payments database as having received $1,634,689 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $284,830 4
2024 General $248,188 4
2023 General $231,288 4
2022 General $257,111 4
2021 General $227,409 4
2020 General $207,685 4
2019 General $178,178 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Steven Gundry
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Steven Gundry were reported at $284,830. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Steven Gundry Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $178,178 $886 $178–$3,167 $163
2020 $207,685 $341 $108–$1,605 $114
2021 $227,409 $453 $125–$1,886 $132
2022 $257,111 $695 $180–$2,566 $149
2023 $231,288 $745 $205–$2,662 $160
2024 $248,188 $799 $214–$2,967 $164
2025 $284,830 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $1,248,827 20 payments
  2. Medtronic Vascular, Inc. $385,863 7 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $1,634,689 27 payments
Products named General payments · program years 2019–2025
  1. BIOMEDICUS $1,021,418 16 payments
  2. Bio-Medicus Cannulae $385,863 7 payments
  3. Bio-Medicus Cannulae $227,409 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 10 drugs

Part D claims

284

Prescriptions dispensed, refills included

Drug cost

$24,999

Paid at the pharmacy, in all

Branded share of claims

21.8%

Brand-name drugs, not generics

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Dihydroergotamine Mesylate Generic 14 $15,411
Synthroid Levothyroxine Sodium Brand 29 $4,054
Liothyronine Sodium Generic 61 $2,944
Armour Thyroid Thyroid,pork Brand 11 $1,214
Levothyroxine Sodium Generic 69 $475
Allopurinol Generic 51 $397
Pentoxifylline Generic 12 $186
Metformin Hcl Generic 15 $176
Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid Brand 11 $72
Clopidogrel Clopidogrel Bisulfate Brand 11 $72

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record